With the opening of registration and housing, the 2018 Vascular Annual Meeting officially takes a big step forward. This year's meeting will feature a great mix of activities and initiatives, both familiar and new!
JVS: High-dose angiotensin inhibitors benefit long-term mortality in patients with critical limb ischemia, according to a recent study from Harvard University, published in the March Journal of Vascular Surgery.
To improve access, efficiency and service to existing and future SVS members, the Society is now reviewing and approving membership applications quarterly, instead of yearly.
The Society for Vascular Ultrasound, the Society for Vascular Surgery and Medstreaming-M2S have developed the Vascular Quality Initiative Vascular Ultrasound Registry.
"My group manages eight hospital labs and a physician group-owned outpatient lab that provides services in nine outpatient clinics… We are critically dependent on appropriate reimbursement for vascular ultrasound services to be able to maintain the high-quality service we provide in the commu
The clock is ticking to apply for a new SVS Foundation grant program aimed squarely at improving patient health by way of our community practice members.
2017 was a great year for SVS public relations efforts. SVS sent out a regular stream of press releases, pitches and media advisories aimed at both patients and professionals and responded to media requests for information.
The program is taking shape and registration is now open for an important SVS research-oriented event, the Vascular Research Initiatives Conference. It will be held May 9 at the Hilton San Francisco Union Square.
A revised and more full-featured website / planner will be a vital tool for VAM participants this year, allowing them to personalize their experience before ever heading to Boston.
SVS members offered their thoughts and recommendations about the Vascular Annual Meeting in several different formats. And those who plan VAM listened, to build on the success of previous years and create a meeting that every member of the vascular team can envision attending.